China Swine Vaccines Market Size & Outlook, 2023-2030
China swine vaccines market, 2018-2030 (US$M)
Related Markets
China swine vaccines market highlights
- The China swine vaccines market generated a revenue of USD 420.6 million in 2023 and is expected to reach USD 610.4 million by 2030.
- The China market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
Swine vaccines market data book summary
| Market revenue in 2023 | USD 420.6 million |
| Market revenue in 2030 | USD 610.4 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
Other key industry trends
- In terms of revenue, China accounted for 25.4% of the global swine vaccines market in 2023.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China swine vaccines market is projected to lead the regional market in terms of revenue in 2030.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 14.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Swine Vaccines Market Scope
Swine Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China swine vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 39.94% in 2023. Horizon Databook has segmented the China swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
High demand for nutritious pork meat, as well as an increase in pork meat production and trade, in China, is expected to boost the market. Presence of the largest pig population in China, cheap labor costs, and availability of a cooperative pork producer network are contributing to market growth.
Rise in the incidence of numerous infectious diseases is a significant factor driving the market growth. Foot-and-mouth disease is a highly contagious disease that threatens and hinders the growth of China's cattle industry. it also affects the health of animals such as pigs, cattle, and sheep.
The National Foot and Mouth Disease Reference Laboratory is the official institution for detecting and confirming foot-and mouth disease in the country. It is an epidemic that has a significant impact on food safety and animal husbandry.
Reasons to subscribe to China swine vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China swine vaccines market databook
-
Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into China swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China swine vaccines market size, by vaccine type, 2018-2030 (US$M)
China Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
